Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

NCT00002864 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

667

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: octreotide acetate
DRUG: tamoxifen citrate

Sponsor

NCIC Clinical Trials Group